These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37933909)

  • 1. WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer.
    Wang J; Luo J; Wu X; Li Z
    Histol Histopathol; 2024 May; 39(5):633-646. PubMed ID: 37933909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.
    Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
    Wang F; Zhang G; Xu T; Ma J; Wang J; Liu S; Tang Y; Jin S; Li J; Xing N
    J Exp Clin Cancer Res; 2024 Jan; 43(1):24. PubMed ID: 38245792
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Wei W; Sun J; Zhang H; Xiao X; Huang C; Wang L; Zhong H; Jiang Y; Zhang X; Jiang G
    Cancer Res; 2021 Dec; 81(24):6142-6156. PubMed ID: 34702726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELK1 suppresses SYTL1 expression by recruiting HDAC2 in bladder cancer progression.
    Wang J; Luo J; Wu X; Li Z
    Hum Cell; 2022 Nov; 35(6):1961-1975. PubMed ID: 36107384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m6A reader IGF2BP2 promotes M2 macrophage polarization and malignant biological behavior of bladder cancer by stabilizing NRP1 mRNA expression.
    Fu D; Shi X; Yi X; Wu D; He H; Zhou W; Cheng W
    BMC Urol; 2024 Jul; 24(1):147. PubMed ID: 39014364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
    Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGR2-mediated regulation of m
    Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
    Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma.
    Zhang X; Cai X
    Medicine (Baltimore); 2022 Nov; 101(45):e31195. PubMed ID: 36397411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer.
    Liu P; Wu L; Chand H; Li C; Hu X; Li Y
    Life Sci; 2020 Nov; 261():118311. PubMed ID: 32861793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
    Du C; Lv C; Feng Y; Yu S
    J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N
    Yu H; Zhao K; Zeng H; Li Z; Chen K; Zhang Z; Li E; Wu Z
    Biomed Pharmacother; 2021 Jan; 133():111075. PubMed ID: 33378974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
    Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
    J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.